- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03978936
Medication Adherence With Telehealthcare Medication Therapy Management (MATCH)
April 9, 2024 updated by: Johns Hopkins University
Improving Medication Adherence With Telehealthcare Medication Therapy Management to Change Health Outcomes in Adolescents and Young Adults With Asthma
Improving Medication Adherence with Telehealthcare Medication Therapy Management to Change Health Outcomes in Adolescents and Young Adults with Asthma (MATCH) is a multi-center, randomized parallel group study targeted to an at-risk population of Adolescents and Young Adults (AYA) with uncontrolled asthma who have poor adherence with prescribed Inhaled corticosteroid (ICS) therapy.
Study Overview
Status
Active, not recruiting
Conditions
Detailed Description
The study evaluates a Medication Therapy Management (MTM) video telehealthcare intervention to address poor medication adherence.
In addition, it employs a novel method to track and provide feedback to participants on adherence by using Propeller Sensors.
300 adolescents and young adults will be randomized to Medication Therapy Management (MTM) video telehealthcare plus electronic adherence self-management [MTM EAM] or electronic adherence self-management alone (EAM).
Due to the hierarchal design of the trial, two primary outcomes to be tested in a sequential manner are specified, adherence and time to first asthma exacerbation.
Study Type
Interventional
Enrollment (Estimated)
300
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Heather Hazucha, MPH
- Phone Number: 410-502-0585
- Email: hhazuch1@jhu.edu
Study Locations
-
-
Alabama
-
Birmingham, Alabama, United States, 35249
- University of Alabama at Birmingham
-
-
Arizona
-
Tucson, Arizona, United States, 85724
- University of Arizona
-
-
California
-
San Francisco, California, United States, 94143
- University of California at San Francisco
-
-
Colorado
-
Denver, Colorado, United States, 80206
- National Jewish Medical and Research Center
-
-
Florida
-
Jacksonville, Florida, United States, 32207
- Nemours Children's Specialty Care
-
Jacksonville, Florida, United States, 32209
- University of Florida College of Medicine
-
-
Illinois
-
Chicago, Illinois, United States, 60611
- Northwestern University
-
Chicago, Illinois, United States, 60612
- Rush University Medical Center
-
Chicago, Illinois, United States, 60608
- University of Illinois at Chicago
-
Chicago, Illinois, United States, 60637
- University of Chicago Hospitals
-
-
Kansas
-
Kansas City, Kansas, United States, 66103
- University of Kansas Medical Center
-
-
Michigan
-
Ann Arbor, Michigan, United States, 48109-5360
- University of Michigan
-
-
Missouri
-
Kansas City, Missouri, United States, 64108
- Children's Mercy Hospital
-
-
New York
-
New York, New York, United States, 10016
- New York University School of Medicine
-
New York, New York, United States, 10029
- Mount Sinai National Jewish Health Respiratory Institute; Icahn School of Medicine
-
New York, New York, United States, 10029
- Columbia University Medical Center
-
-
North Carolina
-
Durham, North Carolina, United States, 27710
- Duke University Medical Center
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, United States, 19140
- Temple University
-
-
Texas
-
Houston, Texas, United States, 77030
- Baylor College of Medicine
-
-
Vermont
-
Colchester, Vermont, United States, 05466
- Vermont Lung Center at The University of Vermont
-
-
Washington
-
Seattle, Washington, United States, 98108
- Pacific Northwest Airways - VA Puget Sound Healthcare System
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
12 years to 35 years (Child, Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Age 12 through 35 years
- Speaks English or Spanish
- Physician diagnosed asthma (without any other co-morbid pulmonary disease)
- Prescribed ICS treatment for at least 3 months prior to screening
- Adherence to Refills and Medication Scale (ARMS) 7-item questionnaire score of >8 (low or moderate adherence)
- Current use of albuterol metered dose inhaler (MDI) for rescue: ProAir, Ventolin, albuterol sulfate (from Prasco or Teva)
- Uncontrolled asthma:
- Symptomatic asthma defined as 3 of the following in the past 4 weeks:
- Daytime symptoms of asthma more than twice per week
- Any night awakening due to asthma
- Rescue inhaler use for symptoms more than twice per week
- Any activity limitation due to asthma; OR
- Asthma Control Test score ≤19
- Has iPhone or Android smart phone with Short Message Service (SMS)
- Has access to reliable WiFi service and a device with capability for telemedicine study visits
- Ability to understand and willingness to sign consent documents
- Evidence of Propeller sensor connection in the 4-week run-in period
Exclusion Criteria:
- Use of an investigational treatment in the previous 30 days.
- Previous enrollment in MATCH Structured Interviews ( Aim 1)
- Currently enrolled in an intervention trial
- Currently uses an ICS not compatible with the Propeller sensor
- Inability to comply with study procedures, including:
- Inability or unwillingness to provide informed consent (or assent in the case of a minor).
- Inability to perform study measurements.
- inability to be contacted by phone via calls and /or text messaging
- Not willing to have video chat
- Any condition(s) in the opinion of the physician that puts the participant at risk from participating in the study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: MTM-EAM
Medication Therapy Management Video Telehealthcare plus Electronic Adherence Self-Management [MTM-EAM]
|
MTM is an individualized approach to "optimize medication use for improved patient outcomes" and is designed to "empower patients to take an active role in managing patients' medications" thus, providing a favorable strategy for addressing adherence issues.
Five core elements define MTM: complete medication therapy review (CMR), creation of a personal medication list (PML), development of a medication action plan (MAP), intervention and/or referral for drug therapy problems, and documentation and follow-up
Participants will have a sensor which monitors their adherence to medication use
|
Active Comparator: EAM only
Electronic Adherence Self-Management [EAM] only
|
Participants will have a sensor which monitors their adherence to medication use
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Time (days) to first exacerbation event
Time Frame: 12 months
|
Time to first asthma exacerbation is the time to first exacerbation event defined as a worsening of asthma requiring the use of systemic corticosteroids for at least 3 days, or asthma-specific emergency department visit with treatment with systemic corticosteroids, or asthma-specific hospitalization, or death (all cause and asthma exacerbation).
104.
These data will be collected by self-report in the "My Asthma" bi-weekly assessment questionnaire, and verified by the study site coordinator with the participant's provider.
|
12 months
|
Proportion of adherent days as assessed by Propeller sensors
Time Frame: 12 months
|
Adherence will be measured using data collected from Propeller sensors.
Adherence for each day is calculated as the number of inhalations taken divided by the expected number of doses.
A day will be defined as adherent if the participant completes 80% or more of the prescribed inhalations.
The primary outcome will be the proportion of adherent days over the course of follow-up, i.e. from the randomization visit to the 1-year visit.
|
12 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Kathryn Blake, Pharm.D, Nemours Children's Specialty Care
- Principal Investigator: Robert Wise, MD, Johns Hopkins School of Medicine
- Principal Investigator: Janet Holbrook, PhD, Johns Hopkins Bloomberg School of Public Health
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 18, 2019
Primary Completion (Estimated)
January 31, 2025
Study Completion (Estimated)
June 30, 2025
Study Registration Dates
First Submitted
June 5, 2019
First Submitted That Met QC Criteria
June 5, 2019
First Posted (Actual)
June 7, 2019
Study Record Updates
Last Update Posted (Actual)
April 11, 2024
Last Update Submitted That Met QC Criteria
April 9, 2024
Last Verified
April 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB00197194
- 1R01HL136945-01A1 (U.S. NIH Grant/Contract)
- 3R01HL136945-01A1S1 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Young Adults
-
University of Wisconsin, MadisonNational Institute of Mental Health (NIMH)Completed
-
Riphah International UniversityRecruiting
-
University of California, Los AngelesCompleted
-
Charite University, Berlin, GermanyPhysikalisch-Technische Bundesanstalt Institut Berlin (PTB)CompletedHealthy Young AdultsGermany
-
University of RochesterCompleted
-
Escola Superior de Tecnologia da Saúde do PortoNot yet recruitingHealthy Young AdultsPortugal
-
Riphah International UniversityCompletedHealthy Young AdultsPakistan
-
Pamukkale UniversityCompleted
-
Georgia Institute of TechnologyNational Institute of Neurological Disorders and Stroke (NINDS)CompletedHealthy Young AdultsUnited States
Clinical Trials on Medication Therapy Management (MTM) Video Telehealthcare
-
HealthEast Care SystemUniversity of MinnesotaCompleted
-
Duke UniversityNational Institute of General Medical Sciences (NIGMS)Completed
-
Tabula Rasa HealthCareCompletedPharmacogenomics | Medication Therapy ManagementUnited States
-
University of Illinois at ChicagoDuke University; Baylor Research Institute; RTI International; Agency for Healthcare...CompletedElderly Patients | Chronic Illness | Adverse Effects | Medication ErrorsUnited States
-
University of North Texas Health Science CenterUniversity of California, San Francisco; University of Minnesota; Walgreens,...Active, not recruitingHypertension | Diabetes Mellitus, Type 2 | HIV/AIDSUnited States
-
Ohio State UniversityWithdrawnMedication Therapy Management | Medication Management | Estimated Cost Avoidance | MTM
-
Daniela MogaNational Institute on Aging (NIA); Northern California Institute of Research...TerminatedDementia | Mild Cognitive ImpairmentUnited States
-
University Hospital, ToulouseCompletedMedication Therapy ManagementFrance
-
University Hospital, ToulouseInstitut National de la Santé Et de la Recherche Médicale, FranceCompletedMedication Therapy ManagementFrance
-
University of Colorado, DenverAgency for Healthcare Research and Quality (AHRQ)RecruitingChild, Only | Medication Compliance | Medication Administered in Error | Disabilities Multiple | Medication InteractionUnited States